[1]
2025. The Efficacy of Anthracycline- and Taxane-Containing Neoadjuvant Chemotherapy in Luminal HER2-Negative BRCAmut Breast Cancer. Voprosy onkologii. 71, 3 (Jun. 2025), OF-2280. DOI:https://doi.org/10.37469/0507-3758-2025-71-3-OF-2280.